These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4679248)

  • 1. [Studies on long-term tolerance of glibornuride in the rat and in the dog].
    Schärer K; Heisler N; Sterner W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2188. PubMed ID: 4679248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tolerance test of HB 419 in animal experiments].
    Hebold G; Scholz J; Schütz E; Czerwek H; Brunk R
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1404-13. PubMed ID: 5394461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 4. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
    Nava M; Quibrera R; Pérez Arocha N
    Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609
    [No Abstract]   [Full Text] [Related]  

  • 5. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].
    Ewald W; Hartmann HM; Haupt E; Kunkel W; Neubauer M; Bartelt KM; Beyer J; Cordes U; Schulz F; Schöffling K
    Med Klin; 1973 Mar; 68(12):376-85. PubMed ID: 4806346
    [No Abstract]   [Full Text] [Related]  

  • 7. Subchronic and chronic toxicity of the new sulfonylurea glimepiride in dogs.
    Schollmeier U; Brunk R; Mayer D
    Arzneimittelforschung; 1993 Oct; 43(10):1068-71. PubMed ID: 8267671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxicological studies of N-4-2-(5-chloro-2-methoxybenzamido)-ethyl-phenylsulfonyl-n'-cyclohexylurea (HB 419)].
    Mizukami K; Miyamoto M; Hayashi S; Kobayashi T; Sakurai M; Sakaguchi T
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1413-9. PubMed ID: 5395701
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute, subchronic and chronic toxicity of the new sulfonylurea glimepiride in rats.
    Donaubauer HH; Mayer D
    Arzneimittelforschung; 1993 May; 43(5):547-9. PubMed ID: 8328999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological study on bamifylline.
    Georges A; Dusart P; Gerin Y; Denef J
    Arzneimittelforschung; 1968 Apr; 18(4):460-6. PubMed ID: 5754939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Three-year experience with the antidiabetic glibornurid (Glutril)].
    Hammerl H; Henk W; Köhn H; Kränzl C; Pichler O; Studlar M
    Wien Med Wochenschr; 1974 Jul; 124(27):448-52. PubMed ID: 4210108
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
    Polacek I; Schulze E; Burg H; Ouart J
    Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood sugar reducing sulfonylureas with substituted cyclohexyl rest].
    Weyer R; Weber H; Aumüller W; Korger G; Muth K; Pfaff W; Bänder A
    Arzneimittelforschung; 1969 Feb; 19(2):140-3. PubMed ID: 5818749
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of oral hypoglycemic agents.
    Seltzer HS
    Annu Rev Med; 1980; 31():261-72. PubMed ID: 6994611
    [No Abstract]   [Full Text] [Related]  

  • 18. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G; Dalla Vedova R; Cadel S; Campi G; Wassermann A
    Boll Chim Farm; 1978 Jun; 117(6):348-67. PubMed ID: 743381
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cerebrocrast on body and organ weights, food and water intake, and urine output of normal rats.
    Briede J; Stivrina M; Stoldere D; Vigante B; Duburs G
    Cell Biochem Funct; 2008 Dec; 26(8):908-15. PubMed ID: 19039818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.